Dr. Euguenia Kharmlampieva, CNMB Co-director, is among 3 UAB chemists fighting cancer. Kharlampieva and Veronika Kozlovskaya, Ph.D., research associate in Kharlampieva’s lab and her longtime collaborator, have created a cloaking device for fragile anti-cancer drugs. Their nanocapsules can be 60 times smaller than a red blood cell and produced at industrial scale. And they are smart; that is, they can release their cargo at precise locations when triggered by a burst of ultrasound energy, a specified temperature or the acidic environment around cancer cells. Click here to see original article in it’s entirety as published in the UAB Reporter.
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2024 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.